Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
Ramón Cacabelos, Clara Torrellas
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 12, pp. 30483-30543
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
Ramón Cacabelos
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 3, pp. 551-551
Open Access | Times Cited: 499
Epigenetics of Alzheimer’s Disease
Matea Nikolac Perković, Alja Videtič Paska, Marcela Konjevod, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 195-195
Open Access | Times Cited: 130
Histone Modifications in Alzheimer’s Disease
Dalileia Aparecida Santana, Marı́lia de Arruda Cardoso Smith, Elizabeth Chen
Genes (2023) Vol. 14, Iss. 2, pp. 347-347
Open Access | Times Cited: 62
Pharmaco-Multiomics: A New Frontier in Precision Psychiatry
Dhoha Dhieb, Kholoud Bastaki
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1082-1082
Open Access | Times Cited: 2
Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
Mayuri Shukla, Piyarat Govitrapong, Parichart Boontem, et al.
Current Neuropharmacology (2017) Vol. 15, Iss. 7
Open Access | Times Cited: 164
Anti-aging pharmacology: Promises and pitfalls
Alexander Vaiserman, Oleh Lushchak, Alexander Koliada
Ageing Research Reviews (2016) Vol. 31, pp. 9-35
Closed Access | Times Cited: 129
The role of pharmacogenomics in adverse drug reactions
Ramón Cacabelos, Natalia Cacabelos, Juan C. Carril
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 5, pp. 407-442
Closed Access | Times Cited: 98
Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer’s Disease
Andrea Stoccoro, Gabriele Siciliano, Lucia Migliore, et al.
Journal of Alzheimer s Disease (2017) Vol. 59, Iss. 2, pp. 559-564
Open Access | Times Cited: 92
HDAC inhibitors: A new promising drug class in anti-aging research
E. G. Pasyukova, Alexander Vaiserman
Mechanisms of Ageing and Development (2017) Vol. 166, pp. 6-15
Closed Access | Times Cited: 90
Dysregulation of Epigenetic Mechanisms of Gene Expression in the Pathologies of Hyperhomocysteinemia
Joanna Perła‐Kaján, Hieronim Jakubowski
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3140-3140
Open Access | Times Cited: 79
Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 12
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1
Epigenetic drug discovery for Alzheimer’s disease
Ramón Cacabelos, Clara Torrellas
Expert Opinion on Drug Discovery (2014) Vol. 9, Iss. 9, pp. 1059-1086
Closed Access | Times Cited: 78
Sirtuins in Alzheimer’s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics
Ramón Cacabelos, Juan C. Carril, Natalia Cacabelos, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1249-1249
Open Access | Times Cited: 76
Can ovarian aging be delayed by pharmacological strategies?
Jinjin Zhang, Qian Chen, Dingfu Du, et al.
Aging (2019) Vol. 11, Iss. 2, pp. 817-832
Open Access | Times Cited: 70
Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years?
Ramón Cacabelos
Expert Opinion on Drug Discovery (2018) Vol. 13, Iss. 6, pp. 523-538
Closed Access | Times Cited: 62
Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model
Christian Griñán‐Ferré, Laura Marsal-García, Aina Bellver‐Sanchís, et al.
Aging (2019) Vol. 11, Iss. 23, pp. 11591-11608
Open Access | Times Cited: 62
The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions
Rachel Keszycki, Daniel Fisher, Hongxin Dong
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 59
Epigenetic mechanisms of neurodegenerative diseases and acute brain injury
Mario J. Bertogliat, Kahlilia C. Morris-Blanco, Raghu Vemuganti
Neurochemistry International (2019) Vol. 133, pp. 104642-104642
Open Access | Times Cited: 55
Promises and challenges in pharmacoepigenetics
Delaney A. Smith, Marie C. Sadler, Russ B. Altman
Cambridge Prisms Precision Medicine (2023) Vol. 1
Open Access | Times Cited: 20
Deciphering Depression: Epigenetic Mechanisms and Treatment Strategies
Alaa A. A. Aljabali, Almuthanna K. Alkaraki, Omar Gammoh, et al.
Biology (2024) Vol. 13, Iss. 8, pp. 638-638
Open Access | Times Cited: 8
Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases
Óscar Teijido, Ramón Cacabelos
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3199-3199
Open Access | Times Cited: 57
The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies
Ana C. Silveira, Jane Dias, Vanessa M. Santos, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 7, pp. 590-613
Open Access | Times Cited: 51
Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome
Agnieszka Gadecka, Anna Bielak-Żmijewska
Nutrients (2019) Vol. 11, Iss. 6, pp. 1251-1251
Open Access | Times Cited: 50
Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
Anna Atlante, Giuseppina Amadoro, Antonella Bobba, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2347-2347
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top